Nadege Morisot

Nadege Morisot has worked in a variety of roles in the life sciences field since 2010. Nadege began their career as a Research Intern at Servier, where they studied the implication of the neurotransmitter glutamate in schizophrenia. From 2010 to 2014, they were a PhD Student at Université de Bordeaux, where they investigated the role of the brain stress-responsive system in drug addiction. From 2014 to 2017, they were a Senior Scientist at Charles River Laboratories, where they directed in vivo pharmacological, behavioral and PK/PD studies to evaluate the therapeutic potential of candidate drug compounds in preclinical models. From 2020 to 2022, they were a Principal Scientist and Senior Scientist at Nkarta, Inc. and is currently an Associate Director of Translational Biology at Earli Inc.

Nadege Morisot obtained their Doctor of Philosophy (Ph.D.) in Neuroscience from Université de Bordeaux in 2013. Prior to this, they obtained their Master's Degree in Neuroscience from Université de Bordeaux in 2010.